Clinical Trials
Biotechs Recursion, Exscientia Merge For $850M And 10 Trials
The resultant biotech, which the businesses announced on Thursday, would have a pipeline that may produce 10 clinical readouts over the next 18 months, with a combined cash of $850 million.
According to a statement made on Thursday, the AI-enabled...
Clinical Trials
Key Factors In Clinical Trial Management And Cost Control
Running a clinical study entails significant costs and necessitates collaboration among sponsors, vendors, CROs, and sites to ensure trial success.
At the 13th Annual Clinical Trials in Oncology East Coast 2024 conference in Burlington, Massachusetts, panelists discussed the factors influencing...
Clinical Trials
Clinical Trial Supplies Market To Reach $3.72 Bn In 2028
The market for clinical trial supplies has shown strong growth recently, expanding from $2.52 billion in 2023 to $2.75 billion in 2024, with a compound annual growth rate (CAGR) of 8.9%. This growth in the historical period is attributed...
Clinical Trials
FDA New Rules For Broader Representation In Drug Testing
The FDA has made progress in promoting diversity in clinical trials. Recently, the agency published a draft guidance providing more information on how sponsors can develop Diversity Action Plans to ensure trial participants better reflect the populations that will...
Clinical Trials
US Clinical Trials Supply & Logistics Market: A Growth Story
As per a study conducted in May 2024, the US clinical trials supply and logistics market size was placed at $1.90 billion in 2023 and, in another 10 years, will hit $3.95 billion, thereby growing at an impressive CAGR...
Clinical Trials
Data from the first human study demonstrate excellent performance of Zerion Pharmas Dispersome technology
Zerion Pharma A/S announces positive results from the first human clinical study of a Dispersome® formulation of the drug Ivacaftor, a pharmaceutical used to treat cystic fibrosis. The study was conducted by ZERION’s Spanish partner Insud Pharma, a global...
Clinical Trials
Can Clinical Research Spectrum Make The Most of Gene Therapy
It is a well-established fact that gene therapy research happens to be booming. Since the U.S. Food and Drug Administration- FDA issued its first approval when it comes to gene therapy in 2017, oncology researchers have gone on to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
